本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Biohaven Pharmaceutical Holding Co Ltd.

22.85
+0.40001.78%
盘后22.850.00000.00%16:54 EDT
成交量:210.15万
成交额:4,906.87万
市值:23.32亿
市盈率:-2.46
高:24.06
开:22.98
低:22.50
收:22.45
数据加载中...
2024/03/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/06

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K - Current report
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/29

重要事件披露

Form 8-K - Current report
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/12

重要事件披露

Form 8-K - Current report
2022/10/04

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities